Neurological signs in relation to white matter hyperintensity volumes in memory clinic patients

Dementia and Geriatric Cognitive Disorders

Volumn 29, Issue 4, 2010, Pages 301-308

  Staekenborg, S S ^a   De Waal, H ^a   Admiraal Behloul, F ^c   Barkhof, F ^b   Reiber, J H C ^c   Scheltens, P ^a   Pijnenburg, Y A L ^a   Vrenken, H ^b   Van Der Flier, W M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Magnetic resonance imaging; Neurological signs; White matter hyperintensities

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER HYPERINTENSITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BASAL GANGLIA DISEASES; BRAIN; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL RECORDS; MEMORY DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES;

EID: 77950611853     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000254791     Document Type: Article

References (36)

1. Louis ED, Tang MX, Mayeux R: Parkinsonian signs in older people in a communitybased study: risk of incident dementia. Arch Neurol 2004; 61: 1273-1276.
2. Torres HA, Fratiglioni L, Hofman W, Winblad B: Early symptoms and neurological findings in demented subjects from a community survey. Alzheimer Dis Assoc Disord 1995; 9: 170-175.
3. Waite LM, Broe GA, Creasey H, Grayson D, Edelbrock D, O'Toole B: Neurological signs, aging, and the neurodegenerative syndromes. Arch Neurol 1996; 53: 498-502.
4. Burns A, Jacoby R, Levy R: Neurological signs in Alzheimer's disease. Age Ageing 1991; 20: 45-51.
5. Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y: Motor signs predict poor outcomes in Alzheimer disease. Neurology 2005; 64: 1696-1703.
6. Ellis RJ, Caligiuri M, Galasko D, Thal LJ: Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord 1996; 10: 103-114.
7. Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y: Motor signs during the course of Alzheimer disease. Neurology 2004; 63: 975-982.
8. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.
9. Staekenborg SS, van der Flier WM, van Straaten EC, Lane R, Barkhof F, Scheltens P: Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke 2008; 39: 317-322.
10. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
11. Kumamoto T, Sannomiya K, Ueyama H, Aoki K, Nakashima T, Nakamura R, Tsuda T: Neurological abnormalities in cognitively impaired but not demented elderly. Acta Neurol Scand 2000; 102: 292-298.
12. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA: Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol 2006; 63: 1763-1769.
13. Boyle PA, Wilson RS, Aggarwal NT, Arvanitakis Z, Kelly J, Bienias JL, Bennett DA: Parkinsonian signs in subjects with mild cognitive impairment. Neurology 2005; 65: 1901-1906.
14. Attems J, Quass M, Jellinger KA: Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathol 2007; 113: 53-62.
15. Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW: The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 2005; 64: 1397-1403.
16. Louis ED, Luchsinger JA: History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals. Arch Neurol 2006; 63: 717-722.
17. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28: 652-659.
18. Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA: Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008; 71: 108-113.
19. Rektor I, Rektorova I, Kubova D: Vascular parkinsonism-an update. J Neurol Sci 2006; 248: 185-191.
20. Yamanouchi H, Nagura H: Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 1997; 28: 965-969.
21. Reitz C, Trenkwalder C, Kretzschmar K, Roesler A, Eckardstein V, Berger K: Relation of cerebral small-vessel disease and brain atrophy to mild Parkinsonism in the elderly. Mov Disord 2006; 21: 1914-1919.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
23. Admiraal-Behloul F, van den Heuvel DM, Olofsen H, van Osch MJ, van der Grond J, van Buchem MA, Reiber JH: Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 2005; 28: 607-617.
24. van Es AC, van der Flier WM, Admiraal-Behloul F, Olofsen H, Bollen EL, Middelkoop HA, Weverling-Rijnsburger AW, van der Grond J, Westendorp RG, van Buchem MA: Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging. AJNR Am J Neuroradiol 2007; 28: 1938-1942.
25. Zilles K, Rehkamper G: Funktionelle Neuroanatomie: Lehrbuch und Atlas. Berlin, Springer, 1998.
26. Dave R, Krishnapuram R: Robust clustering methods: a unified view. IEEE Trans Fuzzy Syst 1997; 5: 270-293.
27. Benassi G, D'Alessandro R, Gallassi R, Morreale A, Lugaresi E: Neurological examination in subjects over 65 years: an epidemiological survey. Neuroepidemiology 1990; 9: 27-38.
28. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ: Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008; 131: 3286-3298.
29. Thompson PM, Moussai J, Zohoori S, Goldkorn A, Khan AA, Mega MS, Small GW, Cummings JL, Toga AW: Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex 1998; 8: 492-509.
30. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW: Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994-1005.
31. Boeve BF, Lang AE, Litvan I: Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54(suppl 5): S15-S19.
32. Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I: Alzheimer's disease presenting as corticobasal syndrome. Mov Disord 2006; 21: 2018-2022.
33. Lleo A, Rey MJ, Castellvi M, Ferrer I, Blesa R: Asymmetric myoclonic parietal syndrome in a patient with Alzheimer's disease mimicking corticobasal degeneration. Neurologia 2002; 17: 223-226.
34. Kobayashi K, Shimoda K, Higashima M, Nakano H, Miyazu K, Hayashi M, Tabata O, Koshino Y: Report of three cases of Alzheimer's disease with focal motor symptoms: clinical correlates of neuroimaging findings. World J Biol Psychiatry 2000; 1: 164-169.
35. Kaida K, Takeda K, Nagata N, Kamakura K: Alzheimer's disease with asymmetric parietal lobe atrophy: a case report. J Neurol Sci 1998; 160: 96-99.
36. Sibon I, Fenelon G, Quinn NP, Tison F: Vascular parkinsonism. J Neurol 2004; 251: 513-524.